After years of debilitating bouts of fatigue, Beth VanOrden finally thought she had an answer to her problems in 2016 when she was diagnosed with Hashimoto's disease, an autoimmune disorder.
Nov 29, 2023
0
0
Mercury, pesticides and rare earth metals form a toxic cocktail that a French laboratory announced Tuesday it has found in an unlikely place: on the heads of senators.
Jun 27, 2023
0
15
For individuals with depression, the most common causes of hospitalization are endocrine, musculoskeletal, and vascular diseases, according to a study published online May 3 in JAMA Psychiatry.
May 5, 2023
0
4
Does the COVID-19 pandemic have a silver lining? A recent article by UMass Chan Medical School and UMass Lowell researchers in Humanities and Social Sciences Communications reports that interest among health care professionals ...
Sep 28, 2022
0
28
Traumatic brain injury (TBI) of any severity is associated with increased risk of chronic cardiovascular, endocrine, and neurologic comorbidities, according to a study published online April 28 in JAMA Network Open.
Apr 29, 2022
0
8
Denmark's Novo Nordisk, the world's leading insulin maker, said Thursday it will buy US-based Dicerna Pharmaceuticals, a developer of RNA interference technology which targets genes that cause disease.
Nov 18, 2021
0
1
All adults with endocrine disorders should be tested for high cholesterol and triglycerides to evaluate their risk of heart attack or stroke, according to a Clinical Practice Guideline issued today by the Endocrine Society.
Oct 28, 2020
0
4
(HealthDay)—Adolescent and young adult cancer survivors have a 73 percent higher risk of endocrine diseases, according to a study published online June 29 in JAMA Network Open.
Jul 30, 2018
0
2
Commercially-available prognostic breast cancer tests show significant variation in their abilities to predict disease recurrence, according to a study led by Queen Mary University of London of nearly 800 postmenopausal women.
Feb 15, 2018
0
27
The results of the MONARCH 3 trial, presented at the ESMO 2017 Congress in Madrid, showed that adding the cyclin-dependent kinase (CDK) 4/6 inhibitor abemaciclib to endocrine therapy improved progression-free survival compared ...
Sep 11, 2017
0
1
